Antidepressant agomelatine (AGO) eliminated depression in HFD rats, reduced the activity of inflammatory cytokines (TNF-α, IL-6, and IL-1β), TABRS, and restored the activity of CAT and GPX [51]. Here, IL6 is linked to depressive disorder.